Hématologie
Volume 16, issue 3, mai-juin 2010
Volume 16, issue 3, mai-juin 2010
Éditorial
Use of signatures to identify new therapies: an useful strategy in neoplastic blood disorders
(p.183-4)
François Sigaux
Free Access
Actualités cliniques
Actualités cliniques
(p.185-94)
Free Access
Revue
Will endothelial progenitor cells represent a cell therapy product for the treatment of cardiovascular diseases?
(p.198-207)
David M Smadja, Ivan Bieche, Martine Aiach, Pascale Gaussem
Free Access
Congenital dyserythropoietic anemias
(p.208-21)
Loïc Garçon, Jean Delaunay
Free Access
Haemovigilance of the transfused patient
(p.222-7)
Jean-Yves Py
Free Access
Blood transfusion in the hemopathies at the end of the lifetime: ethical and organisational aspects
(p.228-34)
Dominique Jaulmes, Joël Ceccaldi, Philippe Colombat
Free Access
Mini-revue
Regulation mechanisms controlling fetal hemoglobin expression
(p.235-43)
Dominique Labie
Free Access
Les jeunes hématologistes ont la parole
Refractory or relapsed Hodgkin lymphoma: which treatment for which patients?
(p.244-52)
Tereza Coman
Free Access
Hodgkin lymphoma pathogenesis
(p.253-9)
Géraldine Salmeron
Free Access
Note technique
Evaluation of the eosin-5-maleimide flow cytometric test for the diagnosis of hereditary spherocytosis
(p.261-3)
Marie Loosveld, Isabelle Arnoux
Free Access